Results from a large study by Italian investigators suggest that ultrasound can predict the risk of stroke in mostly asymptomatic patients based on the assessment of carotid artery plaque morphology, not just stenosis degree. Sonographic surveillance of plaque evolution could boost stroke prevention.
Results from a large study by Italian investigators suggest that ultrasound can predict the risk of stroke in mostly asymptomatic patients based on the assessment of carotid artery plaque morphology, not just stenosis degree. Sonographic surveillance of plaque evolution could boost stroke prevention.
Researchers have previously defined the role of vascular risk factors, such as hypertension and diabetes, in the development of atherosclerosis. The factors that determine the vulnerability of plaque, however, remain controversial.
Physicians dealing with stroke and cardiovascular or cerebrovascular disease should give particular relevance not only to carotid degree of stenosis but also to plaque morphology using ultrasound, said principal investigator Dr. Edoardo Vicenzini of the department of neurological sciences at the University of Rome “La Sapienza.”
“Ultrasound, in the hands of experienced users, is a simple, reliable, low-cost, and diffuse methodology to characterize carotid stenosis,” Vicenzini told Diagnostic Imaging. “The identification of the ‘unstable’ plaque should indeed identify subgroups of patients at major stroke risk who should undergo a more careful, aggressive, and specific primary and secondary prevention strategy.”
Vicenzini and colleagues prospectively enrolled 1655 consecutive patients who underwent ultrasound-based assessments of carotid plaque morphologic characteristics, stenosis degree, and common carotid artery intima-media thickness (IMT). The investigators recorded demographic data, a history of symptomatic cerebrovascular disease, and the presence of vascular risk factors.
They found that hypertension and diabetes correlated with thicker IMTs and more severe, complex plaques. They also found two-thirds of patients with complex plaques were asymptomatic for cerebrovascular disease. Findings appeared in the September issue of the Journal of Ultrasound in Medicine (J Ultrasound Med 2008;27:1313-1319).
Hypertensive and diabetic patients bearing carotid stenosis that is not necessarily hemodynamically significant (>60%) but otherwise seemingly unstable on ultrasound should carefully consider therapy, according to Vicenzini. Signs of unstable plaque are heterogeneity with low echogenicity areas and irregular surface and ulcerations.
Aggressive preventive strategies, including the use of statins, with detailed and strict follow-up every five to six months could be helpful, he said.
“Physicians performing ultrasound and recognizing these features should then precisely identify and describe plaque morphology for further future follow-up investigations to detect texture progression and modifications,” he said.
For more information from the Diagnostic Imaging archives:
Carotid ultrasound predicts stroke, heart attack riskThree-D MRI zeroes in on stroke-inducing carotid artery disease CT imaging detects markers of vulnerable carotid plaqueAdvanced stroke imaging leads to new management challenges
MRI or Ultrasound for Evaluating Pelvic Endometriosis?: Seven Takeaways from a New Literature Review
September 13th 2024While noting the strength of MRI for complete staging of disease and ultrasound’s ability to provide local disease characterization, the authors of a new literature review suggest the two modalities offer comparable results for diagnosing pelvic endometriosis.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
FDA Clears Controlled Contrast Delivery Method for Ultrasound Imaging of Fallopian Tubes
September 9th 2024Facilitating natural contrast delivery through an intrauterine catheter, FemChec can be utilized for ultrasound assessment of fallopian tubes and may provide diagnostic confirmation for an emerging non-surgical option for permanent birth control.
FDA Clears Emerging Cardiovascular Point-of-Care Ultrasound Platform
August 22nd 2024Combining four CAD modules for valvular pathologies with a variety of automated measurements, the AI-enabled AISAP Cardio ultrasound system reportedly facilitates up to a 90 percent accuracy rate in detecting common cardiac conditions.
Predicting DCIS Upgrade to Invasive Breast Cancer: Can Contrast-Enhanced Ultrasound Have an Impact?
August 21st 2024Adding two key findings from contrast-enhanced ultrasound to a predictive model of mammography, conventional ultrasound and clinicopathological findings led to a 86.1 percent AUROC for predicting the upgrading of ductal carcinoma in situ to invasive breast cancer, according to new research.